Fei Cao
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Cancer-related molecular mechanisms research (9 papers)Immunotherapy and Immune Responses (7 papers)
- Journals
- Advanced MaterialsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Cao
72 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 600
- Oncology 333
- Cancer Research 306
- Pulmonary and Respiratory Medicine 254
- Immunology 248
Countries citing papers authored by Fei Cao
This map shows the geographic impact of Fei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Cao more than expected).
Fields of papers citing papers by Fei Cao
This network shows the impact of papers produced by Fei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Cao. The network helps show where Fei Cao may publish in the future.
Co-authorship network of co-authors of Fei Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Cao. A scholar is included among the top collaborators of Fei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Cao. Fei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 20 | |
| 13 | 1 | |
| 14 | 12 | |
| 15 | 56 | |
| 16 | 42 | |
| 17 | 19 | |
| 18 | [Preliminary study of apoptotic inhibition and its molecular mechanism of dexamethasone on cisplatin-induced human lung adenocarcinoma cell line SPCA/I]. | 2 |
| 19 | 22 | |
| 20 | 71 |
About Fei Cao
Fei Cao is a scholar working on Otorhinolaryngology, Cancer Research and Developmental Neuroscience, having authored 77 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer-related molecular mechanisms research (9 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Developmental Neuroscience (94 citations), Cancer Research (306 citations) and Oncology (333 citations). Fei Cao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lixue Yin, Liren Qian, Jianming Cai, Jianguo Cui, Shu‐Lin Liu, Weiguo Liu, Lou Zhong, Xiaofeng Yang, Chin Pan and Lewis Cohen. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.